PH19534A - Heterocyclic derivatives - Google Patents

Heterocyclic derivatives

Info

Publication number
PH19534A
PH19534A PH22427A PH22427A PH19534A PH 19534 A PH19534 A PH 19534A PH 22427 A PH22427 A PH 22427A PH 22427 A PH22427 A PH 22427A PH 19534 A PH19534 A PH 19534A
Authority
PH
Philippines
Prior art keywords
heterocyclic derivatives
heterocyclic
derivatives
Prior art date
Application number
PH22427A
Other languages
English (en)
Inventor
John Watson Clitherow
Johan Bradshaw
John Wilson
Macfarlane Mackinnon
Barry John Price
Duncan Bruce Judd
Michael Martin-Smith
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of PH19534A publication Critical patent/PH19534A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/44Iso-indoles; Hydrogenated iso-indoles
    • C07D209/48Iso-indoles; Hydrogenated iso-indoles with oxygen atoms in positions 1 and 3, e.g. phthalimide
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C07D249/101,2,4-Triazoles; Hydrogenated 1,2,4-triazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D249/14Nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/52Radicals substituted by nitrogen atoms not forming part of a nitro radical
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D317/00Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/12Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
PH22427A 1978-04-26 1979-04-26 Heterocyclic derivatives PH19534A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB1646878 1978-04-26
GB7847689 1978-12-08
GB7907422 1979-03-02

Publications (1)

Publication Number Publication Date
PH19534A true PH19534A (en) 1986-05-20

Family

ID=27257387

Family Applications (1)

Application Number Title Priority Date Filing Date
PH22427A PH19534A (en) 1978-04-26 1979-04-26 Heterocyclic derivatives

Country Status (20)

Country Link
US (3) US4318913A (es)
AR (1) AR228941A1 (es)
AT (1) AT376212B (es)
AU (1) AU531224B2 (es)
CA (1) CA1143727A (es)
CH (1) CH647767A5 (es)
DE (2) DE2954639C2 (es)
DK (1) DK173579A (es)
ES (4) ES8102104A1 (es)
FI (1) FI791360A (es)
FR (1) FR2432511B1 (es)
IL (1) IL57178A (es)
IT (1) IT1162304B (es)
LU (1) LU81192A1 (es)
NL (1) NL7903313A (es)
NO (1) NO791387L (es)
NZ (1) NZ190299A (es)
PH (1) PH19534A (es)
SE (1) SE7903698L (es)
YU (2) YU100379A (es)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR228941A1 (es) * 1978-04-26 1983-05-13 Glaxo Group Ltd Procedimiento para preparar nuevos derivados de 3,5-diamino-1,2,4-triazol que son activos contra receptores histaminicos
YU56680A (en) * 1979-03-02 1983-04-30 Glaxo Group Ltd Process for obtaining new 1,2,4-triazole derivatives
US4410523A (en) * 1979-10-22 1983-10-18 Glaxo Group Limited Heterocyclic derivatives
US4777179A (en) * 1979-10-23 1988-10-11 Glaxo Group Limited Heterocyclic derivatives, processes for the use thereof and pharmaceutical compositions containing them
FR2477150A1 (fr) * 1980-02-28 1981-09-04 Glaxo Group Ltd Nouveaux derives heterocycliques, procedes pour leur preparation et compositions pharmaceutiques les comportant
AU548426B2 (en) * 1980-08-27 1985-12-12 Glaxo Group Limited 3-amino-(1,2,4)-triazoles
ATE13057T1 (de) * 1980-12-30 1985-05-15 Glaxo Group Ltd Verfahren zur herstellung eines furanderivates.
DK558181A (da) * 1981-01-30 1982-07-31 Smithkline Corp Fremgangsmaade til fremstilling af 3,5-diamino-1,2,4-triazoler
US4526973A (en) * 1981-05-18 1985-07-02 Bristol-Myers Company Chemical compounds
US4522943A (en) * 1981-05-18 1985-06-11 Bristol-Myers Company Chemical compounds
IE53068B1 (en) * 1981-06-15 1988-05-25 Merck & Co Inc Diamino isothiazole-1-oxides and -1,1-dioxides as gastic secretion inhibitors
EP0070743A3 (en) * 1981-07-22 1983-10-12 Glaxo Group Limited Pharmaceutical compositions containing compounds having action on histamine receptors
CA1192545A (en) * 1982-02-16 1985-08-27 Glaxo Group Limited Heterocyclic derivatives as histamine h.sub.2- antagonists
US4485104A (en) * 1982-02-24 1984-11-27 Glaxo Group Limited 1,2,4-Triazole-3-amines and their pharmaceutical use
US4482552A (en) * 1982-02-26 1984-11-13 Glaxo Group Limited Triazole compounds and their pharmaceutical use
DE3366369D1 (en) * 1982-03-17 1986-10-30 Smith Kline French Lab Pyridine derivatives
US4520025A (en) * 1982-07-21 1985-05-28 William H. Rorer, Inc. Bicyclic nitrogen heterocyclic ethers and thioethers, and their pharmaceutical uses
US4543352A (en) * 1983-04-29 1985-09-24 William H. Rorer, Inc. Naphthalene aminoalkylene ethers and thioethers, and their pharmaceutical uses
US4529723A (en) * 1983-04-29 1985-07-16 William H. Rorer, Inc. Bicyclic benzenoid aminoalkylene ethers and thioethers, pharmaceutical compositions and use
US4481360A (en) * 1983-08-26 1984-11-06 The Upjohn Company 4H-1,2,4-Triazol-3-yl compounds
DE3336410A1 (de) * 1983-10-06 1985-04-18 Ludwig Heumann & Co GmbH, 8500 Nürnberg Sulfenamidderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DE3404786A1 (de) * 1984-02-10 1985-08-14 Ludwig Heumann & Co GmbH, 8500 Nürnberg Neue alkanolderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltendes arzneimittel
US4812451A (en) * 1984-10-19 1989-03-14 A. H. Robins Company, Incorporated 1-(aminoalkyl and aminoalkylamino)carbonyl and thiocarbonyl)-α,.alpha.
US4812452A (en) * 1984-10-19 1989-03-14 A. H. Robins Company, Incorporated 1-((aminoalkyl and aminoalkylamino) carbonyl and thiocarbonyl)-α,α-diarylpyrrolidine, piperidine and homopiperidineacetamides and acetonitriles
EP0226653B1 (de) * 1985-12-20 1989-02-22 LITEF GmbH Verfahren zur Kurswinkelbestimmung mittels und zur automatischen Kalibration eines in einem Luftfahrzeug fest montierten Dreiachsen-Magnetometers
US4988828A (en) * 1987-11-27 1991-01-29 Fujirebio Kabushiki Kaisha Phenoxypropyl derivatives
US5028716A (en) * 1989-01-30 1991-07-02 Taisho Pharmaceutical Co., Ltd. 3,5-diamino-1,2,4-triazole derivatives
GB9009437D0 (en) * 1990-04-26 1990-06-20 Glaxo Group Ltd Chemical compounds
US20230349922A1 (en) 2020-08-11 2023-11-02 Université De Strasbourg H2 Blockers Targeting Liver Macrophages for the Prevention and Treatment of Liver Disease and Cancer

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1419994A (en) 1973-05-03 1976-01-07 Smith Kline French Lab Heterocyclicalkylaminotheterocyclic compounds methods for their preparation and compositions comprising them
SU557574A1 (ru) 1975-07-02 1978-03-05 Ордена Трудового Красного Знамени Научно-Исследовательский Институт Экспериментальной Медицины Амн Ссср Способ получени 3-амино-5-(2-аминоэтил)-1,2,4-триазола
SU596577A1 (ru) 1976-02-23 1978-03-05 Ордена Трудового Красного Знамени Научно-Исследовательский Институт Экспериментальной Медицины -Метил- "/4-(5 амино-1,2,4триазолил-3)-бутил/-тиомочевина, про вл юща антигистаминовую активность, и способ ее получени
GB1565966A (en) * 1976-08-04 1980-04-23 Allen & Hanburys Ltd Aminoalkyl furan derivatives
GB1601459A (en) * 1977-05-17 1981-10-28 Allen & Hanburys Ltd Aminoalkyl thiophene derivatives
IE46886B1 (en) * 1977-05-17 1983-10-19 Allen & Hanburys Ltd Aminoalkyl-benzene derivatives
US4115860A (en) * 1977-06-02 1978-09-19 Lockheed Electronics Co., Inc. Plural load power controller with time-shared processor
DE2835695A1 (de) 1977-08-29 1979-03-15 Yamanouchi Pharma Co Ltd Neue heterocyclische verbindungen, verfahren zu ihrer herstellung und arzneimittel, die diese enthalten
AR228941A1 (es) * 1978-04-26 1983-05-13 Glaxo Group Ltd Procedimiento para preparar nuevos derivados de 3,5-diamino-1,2,4-triazol que son activos contra receptores histaminicos
US4293557A (en) * 1979-07-03 1981-10-06 Teikoku Hormone Mfg. Co., Ltd. Antiulcer phenoxypropylamine derivatives
DE3175201D1 (en) * 1980-04-30 1986-10-02 Merck & Co Inc Aminothiadiazoles as gastric secretion inhibitors
US4390701A (en) * 1981-05-18 1983-06-28 Bristol-Myers Company 1-Amino-2-[3-(3-piperidinomethylphenoxy)propylamino]cyclobutene-3,4-dione
GR77847B (es) * 1981-12-14 1984-09-25 American Home Prod
JPS6067474A (ja) * 1983-09-24 1985-04-17 Wakamoto Pharmaceut Co Ltd 新規な1,3,4−チアジアゾ−ル誘導体及びそれを有効成分とする抗潰瘍剤
DE3513184A1 (de) * 1985-04-12 1986-10-16 Ludwig Heumann & Co GmbH, 8500 Nürnberg 1,3,4-thiadiazolderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel

Also Published As

Publication number Publication date
DK173579A (da) 1979-10-27
FR2432511B1 (fr) 1986-04-25
IT1162304B (it) 1987-03-25
NO791387L (no) 1979-10-29
AT376212B (de) 1984-10-25
ES488676A0 (es) 1980-12-16
IL57178A0 (en) 1979-07-25
SE7903698L (sv) 1979-10-27
AU4648279A (en) 1979-11-01
US4442110A (en) 1984-04-10
CH647767A5 (de) 1985-02-15
ES488677A0 (es) 1980-12-16
DE2954639C2 (es) 1990-09-27
ES8101565A1 (es) 1980-12-16
FR2432511A1 (fr) 1980-02-29
CA1143727A (en) 1983-03-29
ES8101564A1 (es) 1980-12-16
ES8101563A1 (es) 1980-12-16
US4764612A (en) 1988-08-16
NL7903313A (nl) 1979-10-30
ES479988A0 (es) 1980-08-16
YU100379A (en) 1983-04-30
AR228941A1 (es) 1983-05-13
US4318913A (en) 1982-03-09
IL57178A (en) 1984-11-30
DE2917026A1 (de) 1979-11-08
ES8102104A1 (es) 1980-08-16
LU81192A1 (fr) 1980-05-07
IT7948856A0 (it) 1979-04-26
AU531224B2 (en) 1983-08-18
YU16183A (en) 1983-04-30
ES488678A0 (es) 1980-12-16
NZ190299A (en) 1982-05-31
ATA316679A (de) 1984-03-15
FI791360A (fi) 1979-10-27

Similar Documents

Publication Publication Date Title
GB2033893B (en) Tetrazolylalkoxycarbostyril derivatives
PH19534A (en) Heterocyclic derivatives
ZA795239B (en) Heterocyclic compounds
GB2012759B (en) Thienohydantoin derivatives
GB2030979B (en) Heterocyclic derivatives
GB2023133B (en) Heterocyclic derivatives
JPS54154426A (en) Heterocyclic compounds
GB2022079B (en) L-leucyl-4-hydroxyanilide derivatives
ZA801151B (en) Heterocyclic derivatives
ZA792242B (en) Heterocyclic compounds
GB2038326B (en) Acylaniline derivatives
GB2018757B (en) 3-phenyltetrahydropyridine derivatives
GB2017708B (en) Steroid-spirooxazolidinone derivatives
GB2036744B (en) Eburnane derivatives
GB2019843B (en) N-alkenylmoranoline derivatives
GB2017691B (en) 2-hydroxymethyl-pyrazine derivatives
GB2029851B (en) Heterocyclic compounds
GB2024806B (en) Onomycin derivatives
GB2052477B (en) Carbamoyl-piperazine derivatives
GB2013187B (en) Phenylpyrol derivatives
GB2023574B (en) N-cyano-azomethine derivatives
GB2027707B (en) Heterocyclic compounds
GB2013654B (en) Benziosothiazole derivatives
GB2044251B (en) Phenoxypropanolamine derivatives
GB2029828B (en) Vincadifformine derivatives